| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $112.7M | -76.0% |
| Cost of Revenue | $54.5M | +5.2% |
| R&D Expense | $242.5M | +33.6% |
| SG&A Expense | $85.3M | +7.5% |
| Operating Income | -$262.9M | -264.3% |
| Interest Expense | $23.3M | -11.5% |
| Pre-tax Income | -$280.4M | -298.5% |
| Income Tax | -$84K | -100.6% |
| Net Income | -$280.3M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $97.0M | -71.9% |
| Short-term Investments | $267.7M | +138.5% |
| Accounts Receivable | $28.1M | -13.4% |
| Current Assets | $416.0M | -19.8% |
| Total Assets | $833.3M | -25.2% |
| Current Liabilities | $130.4M | -0.0% |
| Total Liabilities | $317.1M | -9.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$207.5M | -194.8% |
| Capital Expenditures | $30.7M | -63.5% |
| Investing Cash Flow | -$11.9M | +97.1% |
| Financing Cash Flow | -$28.8M | -114.8% |
| Free Cash Flow | -$238.2M | -276.8% |
| -319.3% |
| EPS (Basic) | -$6.50 | -315.9% |
| EPS (Diluted) | -$6.50 | -323.4% |
| Stockholders' Equity |
| $516.2M |
| -32.5% |